Evaluation of the Safety and Effectiveness of BOTOX® Injection 50 Units (ClostridiumBotulinum Toxin Type A) for the Treatment of Patients with Moderate to Severe Lateral Canthal Lines (Crow’s Feet Lines) With or Without Simultaneous Glabellar Lines Treatment:A Postmarketing Surveillance Study in Korea

08/11/2016
14/03/2024
EU PAS number:
EUPAS16150
Study
Finalised
Documents
Study protocol
Initial protocol
English (506.61 KB - PDF) View document
Study results
Study results
English (1.29 MB - PDF) View document
Study report
Other information